Collegium Pharmaceutical Inc (COLL)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	166,961	117,030	92,484	67,961	33,319	-12,560	-18,878	-13,579	17,628	66,746	72,223	72,363	56,232	38,863	12,862	-8,695	-23,748	-10,374	-15,185	-17,470
Revenue (ttm)	US$ in thousands	459,924	438,505	430,531	422,636	400,720	314,280	280,041	251,774	255,854	301,783	299,168	291,446	281,134	286,592	361,135	441,180	518,290	515,321	504,149	494,269
Operating profit margin		36.30%	26.69%	21.48%	16.08%	8.31%	-4.00%	-6.74%	-5.39%	6.89%	22.12%	24.14%	24.83%	20.00%	13.56%	3.56%	-1.97%	-4.58%	-2.01%	-3.01%	-3.53%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $166,961K ÷ $459,924K
= 36.30%

Collegium Pharmaceutical Inc's operating profit margin has shown a positive trend over the quarters analyzed. The company's operating profit margin has progressively improved from 7.18% in Q4 2022 to 29.46% in Q4 2023. This indicates that the company has been more efficient in generating profits from its core operations. The consistent increase in the operating profit margin reflects improved cost management and revenue generation strategies. Despite some fluctuations in between, the overall trajectory suggests positive momentum in Collegium Pharmaceutical's operational efficiency and profitability.